UiPath (PATH) delivered earnings and revenue surprises of +20.00% and +3.50%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
Nordhealth AS (STU:6E5) reports a 3.9% increase in Q4 revenue and emphasizes AI-driven innovation amid competitive challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results